COmbination of Radiotherapy With Anti-PD-1 Antibody for unREseCtable Biliary Tract Cancer
NCT03898895
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Biliary Tract Cancer
Radiotherapy
Immunotherapy
Interventions
COMBINATION_PRODUCT:
Radiotherapy+anti-PD-1 antibody
Sponsor
Sun Yat-sen University